WallStSmart

MicroAlgo Inc. (MLGO)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

MicroAlgo Inc. generates 63% more annual revenue ($422.05M vs $258.90M). MLGO leads profitability with a 27.0% profit margin vs -15.5%. MLGO earns a higher WallStSmart Score of 52/100 (C-).

MLGO

Buy

52

out of 100

Grade: C-

Growth: 4.7Profit: 5.0Value: 6.7Quality: 8.5
Piotroski: 3/9Altman Z: 4.38

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for MLGO.

ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MLGO6 strengths · Avg: 9.8/10
P/E RatioValuation
1.9x10/10

Attractively priced relative to earnings

Price/BookValuation
0.1x10/10

Reasonable price relative to book value

EPS GrowthGrowth
502.0%10/10

Earnings expanding 502.0% YoY

Debt/EquityHealth
0.0110/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
4.3810/10

Safe zone — low bankruptcy risk

Profit MarginProfitability
27.0%9/10

Keeps 27 of every $100 in revenue as profit

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

MLGO4 concerns · Avg: 2.8/10
Market CapQuality
$43.55M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
7.5%3/10

ROE of 7.5% — below average capital efficiency

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Revenue GrowthGrowth
-6.8%2/10

Revenue declined 6.8%

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : MLGO

The strongest argument for MLGO centers on P/E Ratio, Price/Book, EPS Growth. Profitability is solid with margins at 27.0% and operating margin at -1.1%.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : MLGO

The primary concerns for MLGO are Market Cap, Return on Equity, Piotroski F-Score.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

MLGO profiles as a declining stock while ZEPP is a hypergrowth play — different risk/reward profiles.

ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor SOFTWARE - INFRASTRUCTURE industry trends, competitive dynamics, and regulatory changes.

Bottom Line

MLGO scores higher overall (52/100 vs 41/100), backed by strong 27.0% margins. ZEPP offers better value entry with a 48.6% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

MicroAlgo Inc.

TECHNOLOGY · SOFTWARE - INFRASTRUCTURE · USA

MicroAlgo Inc. develops and delivers central processing algorithm solutions to customers in internet advertisement, gaming, and intelligent chip industries in the People's Republic of China and internationally. The company is headquartered in Shenzhen, the People's Republic of China.

Visit Website →

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?